Avail upto 30% off on all reports till July 31st.

Phosphodiesterase Type 5 (PDE5) Inhibitor Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Date: Jan 31 2021
|
99Strategy
|
Number of Pages: 110
|
Category: Pharma & Healthcare

Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Phosphodiesterase Type 5 (PDE5) Inhibitor market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Phosphodiesterase Type 5 (PDE5) Inhibitor market segmented into
Sildenafil
Tadalafil
Avanafil
Vardenafil

Based on the end-use, the global Phosphodiesterase Type 5 (PDE5) Inhibitor market classified into
Hospital
Retail Pharmacy
Online Pharmacies
Others
Competitive Landscape:

Based on geography, the global Phosphodiesterase Type 5 (PDE5) Inhibitor market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
Eli Lilly
Pfizer
Bayer
Novartis AG
Merck
GlaxoSmithKline plc
Roche
AstraZeneca
BaiYunShan General Factory
SK Chemicals
Teva Pharma
Dong-A ST
Metuchen Pharma
Seoul Pharma
Vectura Group


Table of Contents
1 RESEARCH SCOPE
    1.1 Research Product Definition
    1.2 Research Segmentation
           1.2.1 Product Type
           1.2.2 Main product Type of Major Players
    1.3 Demand Overview
    1.4 Research Methodology
2 GLOBAL PHOSPHODIESTERASE TYPE 5 (PDE5) INHIBITOR INDUSTRY
    2.1 Summary about Phosphodiesterase Type 5 (PDE5) Inhibitor Industry
    2.2 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Trends
           2.2.1 Phosphodiesterase Type 5 (PDE5) Inhibitor Production & Consumption Trends
           2.2.2 Phosphodiesterase Type 5 (PDE5) Inhibitor Demand Structure Trends
    2.3 Phosphodiesterase Type 5 (PDE5) Inhibitor Cost & Price
3 MARKET DYNAMICS
    3.1 Manufacturing & Purchasing Behavior in 2020
    3.2 Market Development under the Impact of COVID-19
           3.2.1 Drivers
           3.2.2 Restraints
           3.2.3 Opportunity
           3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
    4.1 Region Segmentation (2017 to 2021f)
           4.1.1 North America (U.S., Canada and Mexico)
           4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
           4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
           4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
           4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
    4.2 Product Type Segmentation (2017 to 2021f)
           4.2.1 Sildenafil
           4.2.2 Tadalafil
           4.2.3 Avanafil
           4.2.4 Vardenafil
    4.3 Consumption Segmentation (2017 to 2021f)
           4.3.1 Hospital
           4.3.2 Retail Pharmacy
           4.3.3 Online Pharmacies
           4.3.4 Others
           4.3.5 Competitive Landscape:
5 NORTH AMERICA MARKET SEGMENT
    5.1 Region Segmentation (2017 to 2021f)
           5.1.1 U.S.
           5.1.2 Canada
           5.1.3 Mexico
    5.2 Product Type Segmentation (2017 to 2021f)
           5.2.1 Sildenafil
           5.2.2 Tadalafil
           5.2.3 Avanafil
           5.2.4 Vardenafil
    5.3 Consumption Segmentation (2017 to 2021f)
           5.3.1 Hospital
           5.3.2 Retail Pharmacy
           5.3.3 Online Pharmacies
           5.3.4 Others
           5.3.5 Competitive Landscape:
    5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
    6.1 Region Segmentation (2017 to 2021f)
           6.1.1 Germany
           6.1.2 UK
           6.1.3 France
           6.1.4 Italy
           6.1.5 Rest of Europe
    6.2 Product Type Segmentation (2017 to 2021f)
           6.2.1 Sildenafil
           6.2.2 Tadalafil
           6.2.3 Avanafil
           6.2.4 Vardenafil
    6.3 Consumption Segmentation (2017 to 2021f)
           6.3.1 Hospital
           6.3.2 Retail Pharmacy
           6.3.3 Online Pharmacies
           6.3.4 Others
           6.3.5 Competitive Landscape:
    6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
    7.1 Region Segmentation (2017 to 2021f)
           7.1.1 China
           7.1.2 India
           7.1.3 Japan
           7.1.4 South Korea
           7.1.5 Southeast Asia
           7.1.6 Australia
           7.1.7 Rest of Asia Pacific
    7.2 Product Type Segmentation (2017 to 2021f)
           7.2.1 Sildenafil
           7.2.2 Tadalafil
           7.2.3 Avanafil
           7.2.4 Vardenafil
    7.3 Consumption Segmentation (2017 to 2021f)
           7.3.1 Hospital
           7.3.2 Retail Pharmacy
           7.3.3 Online Pharmacies
           7.3.4 Others
           7.3.5 Competitive Landscape:
    7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
    8.1 Region Segmentation (2017 to 2021f)
           8.1.1 Brazil
           8.1.2 Argentina
           8.1.3 Rest of Latin America
    8.2 Product Type Segmentation (2017 to 2021f)
           8.2.1 Sildenafil
           8.2.2 Tadalafil
           8.2.3 Avanafil
           8.2.4 Vardenafil
    8.3 Consumption Segmentation (2017 to 2021f)
           8.3.1 Hospital
           8.3.2 Retail Pharmacy
           8.3.3 Online Pharmacies
           8.3.4 Others
           8.3.5 Competitive Landscape:
    8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
    9.1 Region Segmentation (2017 to 2021f)
           9.1.1 GCC
           9.1.2 North Africa
           9.1.3 South Africa
           9.1.4 Rest of Middle East and Africa
    9.2 Product Type Segmentation (2017 to 2021f)
           9.2.1 Sildenafil
           9.2.2 Tadalafil
           9.2.3 Avanafil
           9.2.4 Vardenafil
    9.3 Consumption Segmentation (2017 to 2021f)
           9.3.1 Hospital
           9.3.2 Retail Pharmacy
           9.3.3 Online Pharmacies
           9.3.4 Others
           9.3.5 Competitive Landscape:
    9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
    10.1 Brief Introduction of Major Players
           10.1.1 Eli Lilly
           10.1.2 Pfizer
           10.1.3 Bayer
           10.1.4 Novartis AG
           10.1.5 Merck
           10.1.6 GlaxoSmithKline plc
           10.1.7 Roche
           10.1.8 AstraZeneca
           10.1.9 BaiYunShan General Factory
           10.1.10 SK Chemicals
           10.1.11 Teva Pharma
           10.1.12 Dong-A ST
           10.1.13 Metuchen Pharma
           10.1.14 Seoul Pharma
           10.1.15 Vectura Group
    10.2 Phosphodiesterase Type 5 (PDE5) Inhibitor Sales Date of Major Players (2017-2020e)
           10.2.1 Eli Lilly
           10.2.2 Pfizer
           10.2.3 Bayer
           10.2.4 Novartis AG
           10.2.5 Merck
           10.2.6 GlaxoSmithKline plc
           10.2.7 Roche
           10.2.8 AstraZeneca
           10.2.9 BaiYunShan General Factory
           10.2.10 SK Chemicals
           10.2.11 Teva Pharma
           10.2.12 Dong-A ST
           10.2.13 Metuchen Pharma
           10.2.14 Seoul Pharma
           10.2.15 Vectura Group
    10.3 Market Distribution of Major Players
    10.4 Global Competition Segmentation
11 MARKET FORECAST
    11.1 Forecast by Region
    11.2 Forecast by Demand
    11.3 Environment Forecast
           11.3.1 Impact of COVID-19
           11.3.2 Geopolitics Overview
           11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Table
1.Table Phosphodiesterase Type 5 (PDE5) Inhibitor Product Type Overview
2.Table Phosphodiesterase Type 5 (PDE5) Inhibitor Product Type Market Share List
3.Table Phosphodiesterase Type 5 (PDE5) Inhibitor Product Type of Major Players
4.Table Brief Introduction of Eli Lilly
5.Table Brief Introduction of Pfizer
6.Table Brief Introduction of Bayer
7.Table Brief Introduction of Novartis AG
8.Table Brief Introduction of Merck
9.Table Brief Introduction of GlaxoSmithKline plc
10.Table Brief Introduction of Roche
11.Table Brief Introduction of AstraZeneca
12.Table Brief Introduction of BaiYunShan General Factory
13.Table Brief Introduction of SK Chemicals
14.Table Brief Introduction of Teva Pharma
15.Table Brief Introduction of Dong-A ST
16.Table Brief Introduction of Metuchen Pharma
17.Table Brief Introduction of Seoul Pharma
18.Table Brief Introduction of Vectura Group
19.Table Products & Services of Eli Lilly
20.Table Products & Services of Pfizer
21.Table Products & Services of Bayer
22.Table Products & Services of Novartis AG
23.Table Products & Services of Merck
24.Table Products & Services of GlaxoSmithKline plc
25.Table Products & Services of Roche
26.Table Products & Services of AstraZeneca
27.Table Products & Services of BaiYunShan General Factory
28.Table Products & Services of SK Chemicals
29.Table Products & Services of Teva Pharma
30.Table Products & Services of Dong-A ST
31.Table Products & Services of Metuchen Pharma
32.Table Products & Services of Seoul Pharma
33.Table Products & Services of Vectura Group
34.Table Market Distribution of Major Players
35.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
36.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
37.Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Forecast (Million USD) by Region 2021f-2026f
38.Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Forecast (Million USD) Share by Region 2021f-2026f
39.Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Forecast (Million USD) by Demand 2021f-2026f
40.Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Forecast (Million USD) Share by Demand 2021f-2026f

List of Figure
1.Figure Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Phosphodiesterase Type 5 (PDE5) Inhibitor Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Phosphodiesterase Type 5 (PDE5) Inhibitor Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Phosphodiesterase Type 5 (PDE5) Inhibitor Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Sildenafil Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Tadalafil Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Avanafil Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Vardenafil Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Retail Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Online Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Competitive Landscape: Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Sildenafil Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Tadalafil Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Avanafil Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Vardenafil Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Retail Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Online Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Competitive Landscape: Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure Sildenafil Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49dZFkcrKdk7XegyMd3kp4MGQoLFeMWM6Lion2T3q3h6DScBViFrXXuZoxkHq1TB1mGufMoGzfXd7jJ7ocgpJGxdEiGirjGGrowth (%) 2018-2021f
41.Figure Avanafil Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Vardenafil Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Retail Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Online Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Competitive Landscape: Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Sildenafil Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Tadalafil Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Avanafil Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Vardenafil Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Retail Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure Online Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Competitive Landscape: Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Sildenafil Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Tadalafil Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Avanafil Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Vardenafil Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
72.Figure Retail Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
73.Figure Online Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over

Electronic files(PDF) of market research reports will be dispatched within 48-72 hours. (Mon-Fri IST)

Select License Type

Why Choose InForGrowth?
  • Customer Insights
  • Market Opportunity Mapping
  • Competitive Intelligence for Key Companies
  • Market Entry Strategy
  • Product Mix and Pricing
  • Segmentation Analysis
  • Benchmarking Research based on Ecosystem and Interconnectivity
  • Market Attractiveness Framework
  • Demand-Supply Scenario & Performance Optimization
  • Technology Landscape & Revenue Augmenting Plans
  • Impact of Circular Economy or Digital Transformation Trends
  • Region Specific Reports / Country Specific Reports for Specific Topics
  • As Per Customer Need Section Wise Reports
  • Subscription Service with Real-Time Updates
  • Access to all the Research Studies in the Chosen Domains/Verticals
  • Pre and Post-Sales Service and Support
Need Help?
+
x
We use cookies to deliver the best possible experience on our website by improving the user experience, personalizing your visit, and compiling aggregate statistics. By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more visit our Privacy policy page.